-
Harpoon Therapeutics to Participate in Three Upcoming Virtual Investor Conferences
-
UPDATE: Citi Downgrades Harpoon Therapeutics (HARP) to Neutral
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Pre-Open Stock Movers 04/27: (AXSM) (HARP) (AUDC) Higher; (DO) (VSTM) (CAT) Lower (more...)
-
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
-
Harpoon Therapeutics (HARP) PT Lowered to $23 at Citi
-
Citi Assumes Harpoon Therapeutics (HARP) at Buy
-
Citi Starts Harpoon Therapeutics (HARP) at Buy
-
Arix Bioscience plc: Harpoon Closes Initial Public Offering
-
Harpoon Therapeutics (HARP) IPO Opens Flat

